Editorial: Choose choice: The Supreme Court must protect medication abortion

Once again, the U.S. Supreme Court finds itself at the center of a national case involving access to abortion, this time around the drug mifepristone, which along with misoprostol forms part of the regimen for a so-called medication abortion. Its ruling is expected in June, and that ruling should be clear, if only to help clean up the mess it created with its overturning of Roe v. Wade a year and a half ago.